Ken James
Vermogen: 7 004 $ op 31-05-2026
Vermogen: 7 004 $ op 31-05-2026
Ken James is currently Executive Director, Head-Research & Development at Futura Medical Plc since 2016.
Formerly, Mr. James was Director at Futura Medical Developments Ltd. Mr. James was Senior Vice President-Research & Development at Glaxo SmithKline Consumer Healthcare Ltd. from 2006 to 2016.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
FUTURA MEDICAL PLC 0,14% | 31-12-2025 | 799.501 ( 0,14% ) | 7 004 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| FUTURA MEDICAL PLC | Hoofd Techniek/Wetenschap/O&O | 16-11-2016 |
| Bedrijven | Functie | Einde |
|---|---|---|
Glaxo SmithKline Consumer Healthcare Ltd.
Glaxo SmithKline Consumer Healthcare Ltd. Medical DistributorsDistribution Services Manufactures and supplies over the counter drugs | Hoofd Techniek/Wetenschap/O&O | 01-02-2016 |
Futura Medical Developments Ltd.
Futura Medical Developments Ltd. BiotechnologyHealth Technology Develops biological products | Directeur/Bestuurslid | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 3 |
|---|---|
Futura Medical Plc
Futura Medical Plc Pharmaceuticals: OtherHealth Technology Produces pharmaceutical products | Health Technology |
Glaxo SmithKline Consumer Healthcare Ltd.
Glaxo SmithKline Consumer Healthcare Ltd. Medical DistributorsDistribution Services Manufactures and supplies over the counter drugs | Distribution Services |
Futura Medical Developments Ltd.
Futura Medical Developments Ltd. BiotechnologyHealth Technology Develops biological products | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau